Novavax begins vaccine trials; Brazil reports second-highest number of cases in world

Eased lockdowns and lifted restrictions have placed significant pressure on the global drug pipeline.

The global pandemic, which has affected more than 5.5 million, is forcing drugmakers and biotech firms of all sizes to shorten the timeline for a vaccine, which is essential to easing fears about returning to work and school. To-date, nearly a dozen companies in the U.S., Europe and China have started human trials for more than 100 vaccine candidates.

Most recently, Novavax (NVAX) announced it would begin human trials, for its coronavirus vaccine, making it the fourth company in the U.S. to do so. The biotech company is starting its clinical trials in Australia, and intends to produce 100 million doses by the end of the year and a billion doses in 2021.

Meanwhile, Merck (MRK), one of the largest players in the vaccine race, finally unveiled details of its efforts Tuesday. The company announced

Read More

Webinars Examine Current Events And Company Challenges In Brazil

JCP&L workers upgrade the East Windsor substation to enhance service reliability in Mercer County. Presently I am functioning on a couple of enterprise concepts for Bangkok considering that I do keep in Thailand majority of the year. Nevertheless, your dormant ties will probably have distinctive connections and understanding compared to your present network. Jennie briefly worked in newsrooms for local weekly publications prior to moving into public relations, undertaking roles with expert services firms Royal Liver Group and Hill Dickinson and much more lately with major agency Kenyon Fraser and business networking organisation Downtown in Business.

This signifies that any time that you are providing a enterprise presentation you need to make certain that your presentation is packed with existing events. I have thought about carrying organization cards now that I’ve got a decent quantity of hubs. Only time could tell, but in November 2016 a miracle happened, Donald Trump … Read More